Information  X 
Enter a valid email address

Lifeline Scientific (LSI)

  Print      Mail a friend

Wednesday 10 September, 2008

Lifeline Scientific

Directorate Change

RNS Number : 0867D
Lifeline Scientific, Inc
10 September 2008
 



10 September 2008


Lifeline Scientific, Inc

('Lifeline' or 'the Company')


Directorate Change


Lifeline Scientific, the medical technology company, announces the appointment of Klaade Boer (43 years old) as a Non-executive Director with immediate effect.


Mr de Boer is currently Managing Partner of Entrepreneurs Fund Management LLP where he leads the life sciences investment team.  He has over 15 years experience in venture capital and management consultancy and has held a number of positions within or relating to the life sciences and technology sectors. He began his career in 1991 with McKinsey & Co where he spent six years working in the Amsterdam and St Petersburg offices.


He has a MSc. In Applied Physics from Delft University of Technology and a MBA from INSEAD, Fontainbleau.


Mr De Boer speaks Dutch, English, French, German and Russian.


David Kravitz, Chief Executive of Lifeline Scientific, said:

 

'I welcome Klaas to the Board and I'm sure that his experience will be of great value especially as we seek to expand the business internationally.'


Enquiries

Lifeline Scientific, Inc.


David Kravitz, CEO


Seymour Pierce (Nomad)

+44 (0)20 7107 8000

Mark Percy / Huaizheng Peng / Sarah Jacobs


Financial Dynamics

+44 (0)20 7831 3113

Ben Brewerton / John Dineen

 

 

Additional Information on the new Director Appointment:


Mr de Boer is currently a director or partner of the following companies or partnerships:


Entrepreneurs Fund Management Services Limited 

ProtAffin AG

2010 Perfect Vision AG

Optinose AS

Optinose UK Limited

Vasopharm GmbH

Park Road Associates Limited

Tsjukemar Limited

Bridgetools (UK) Limited

Trantor Participates BV

StudioCom.Com, Inc.


Mr De Boer has held the following former directorships within the past five years:


Preferred Global Health Europe Limited

Alvarium Limited

Kantjil Limited


There is no further information required to be disclosed in accordance with Schedule Two paragraph (g) of the AIM Rules in relation to Mr De Boer.



About the LifePort Kidney Transporter

Created with the challenges of organ recovery and transport in mind, LifePort Kidney Transporter is designed to provide improved kidney preservation, evaluation and transport prior to transplantation. LifePort provides a sealed, sterile, protected environment where a solution is gently pumped through the kidney at cold temperatures to minimize damage while the organ is outside the body. LifePort is lightweight and portable, allowing organs to be perfused from the time of recovery until transplant. It is designed to travel unaccompanied by land or air, safely transporting the kidneys across town or between countries. While the kidney is being perfused, the LifePort records data on temperature, flow rate vascular resistance and pressure every 10 seconds providing surgeons with additional data prior to transplant. During its pilot introduction, over 230 LifePorts have been installed in 75 transplant programmes worldwide treating more than 12,000 kidneys.  


About Lifeline Scientific Inc.  

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with European headquarters located in Brussels. Its primary focus is to commercialise its FDA approved, CE marked, clinically validated and revenue generating LifePort Kidney Transporter. Devices for preservation of the heart, lung pancreas and liver are in late stage pre-clinical development. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFGGGLVLFGRZM